首页 正文

Pegtarazimod limits acute graft-versus-host disease mortality and severity in mice and is tolerated in patients

{{output}}
The success of allogeneic hematopoietic cell transplantation (allo-HCT) is limited by acute graft-versus-host disease (aGVHD). We have previously reported that neutrophils can exacerbate tissue damage caused by conditioning regimens. Pegtarazimod is a syntheti... ...